News

Antengene Corporation Limited global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and…
Read More...

AgeX Therapeutics, Inc. a biotechnology company focused on developing therapeutics for human aging and regeneration, announced a research collaboration with the University of…
Read More...

Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, and Foghorn Therapeutics Inc. announced a strategic collaboration to create novel oncology medicines…
Read More...

Pfizer Inc. and Arena Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Arena, a clinical stage company…
Read More...

Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZeneca. The partnership is based on an expanded deal this year in May 2021 which…
Read More...

Novo Nordisk announced plans to invest more than 17 bn Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its…
Read More...

Pfizer Inc. announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor, for the…
Read More...

Rapid Dose Therapeutics Corp. a Canadian biotechnology company revolutionizing drug delivery through innovation, entered into an agreement on Friday, November 26, 2021 with Oakland…
Read More...

Syndax Pharmaceuticals, Inc. announced that the Hart-Scott-Rodino (HSR) antitrust waiting period had expired and that the parties closed the exclusive worldwide collaboration and…
Read More...

Prestige BioPharma Ltd. and Dr. Reddy’s Laboratories Ltd. announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and…
Read More...

AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the…
Read More...

Brii Biosciences Limited, a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced that the…
Read More...

Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo…
Read More...

PacBio and the UCLA Institute for Precision Health and David Geffen School of Medicine at UCLA have formed a research collaboration to further identify the causes of rare diseases. The…
Read More...

GenScript ProBio announced the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province. The…
Read More...

Arbutus Biopharma Corporation, X-Chem, Inc. (X-Chem) and Proteros biostructures GmbH (Proteros) announced that Arbutus Biopharma has identified several molecules that inhibit the…
Read More...

Telix Pharmaceuticals Limited announces that it has entered into an exclusive commercial distribution agreement with Madrid-based NUCLIBER S.A. Spain (NUCLIBER) for Telix’s prostate…
Read More...

Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an anthelmintic, in combination with dexamethasone, an…
Read More...

AstraZeneca has entered into a new global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-LRX. …
Read More...

-      Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global markets.…
Read More...